From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA clears Allergan's $300M glaucoma gel stent

from FierceBiotech

Allergan has been aggressively pursuing treatments for “underserved” eye diseases, shelling out hundreds of millions on a pair of glaucoma device makers in the past 18 months. Now, its bet on a gel stent and injector combo is paying off: It bagged an FDA nod for the treatment of refractory glaucoma. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063